COSCIENS Biopharma Correlations
CSCI Stock | 2.90 0.05 1.75% |
The current 90-days correlation between COSCIENS Biopharma and Puma Biotechnology is 0.15 (i.e., Average diversification). The correlation of COSCIENS Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
COSCIENS Biopharma Correlation With Market
Significant diversification
The correlation between COSCIENS Biopharma and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding COSCIENS Biopharma and DJI in the same portfolio, assuming nothing else is changed.
COSCIENS |
Moving together with COSCIENS Stock
0.93 | VALN | Valneva SE ADR | PairCorr |
0.92 | ERNA | Eterna Therapeutics | PairCorr |
0.9 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.79 | LLY | Eli Lilly | PairCorr |
0.81 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.91 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.66 | INBX | Inhibrx Symbol Change | PairCorr |
0.77 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.9 | MRVI | Maravai Lifesciences | PairCorr |
0.91 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.74 | ABBV | AbbVie Inc | PairCorr |
0.79 | AKAN | Akanda Corp | PairCorr |
0.93 | AMGN | Amgen Inc | PairCorr |
0.74 | ANRO | Alto Neuroscience, | PairCorr |
0.7 | APGE | Apogee Therapeutics, | PairCorr |
0.68 | ARDX | Ardelyx | PairCorr |
0.7 | AVDL | Avadel Pharmaceuticals | PairCorr |
0.69 | SMMT | Summit Therapeutics PLC | PairCorr |
Moving against COSCIENS Stock
0.89 | BMY | Bristol Myers Squibb | PairCorr |
0.82 | ESPR | Esperion Therapeutics | PairCorr |
0.74 | GILD | Gilead Sciences | PairCorr |
0.73 | DYAI | Dyadic International | PairCorr |
0.49 | DNA | Ginkgo Bioworks Holdings Sell-off Trend | PairCorr |
0.7 | MNMD | Mind Medicine | PairCorr |
0.63 | ABCL | Abcellera Biologics | PairCorr |
0.34 | MOLN | Molecular Partners | PairCorr |
0.88 | TARS | Tarsus Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between COSCIENS Stock performing well and COSCIENS Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze COSCIENS Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PBYI | 2.86 | 0.23 | 0.05 | 0.22 | 4.41 | 5.17 | 33.65 | |||
IOVA | 3.17 | (0.49) | 0.00 | (0.17) | 0.00 | 7.18 | 22.30 | |||
SNDX | 2.53 | (0.34) | 0.00 | (0.57) | 0.00 | 4.02 | 34.00 | |||
PTGX | 1.95 | (0.27) | 0.00 | (0.12) | 0.00 | 3.42 | 16.19 |
COSCIENS Biopharma Corporate Executives
Elected by the shareholders, the COSCIENS Biopharma's board of directors comprises two types of representatives: COSCIENS Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of COSCIENS. The board's role is to monitor COSCIENS Biopharma's management team and ensure that shareholders' interests are well served. COSCIENS Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, COSCIENS Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Giuliano Fratta | Senior CFO | Profile |